About Zinc finger protein 789
Zinc finger protein 789 (ZNF789) is a protein
from Homo sapiens identified by UniProt accession
Q5FWF6, 425 residues long.
MolForge cross-references it against 0 known binders and
55 disease associations.
Target properties
| Protein name | Zinc finger protein 789 |
| UniProt accession | Q5FWF6 |
| Gene | ZNF789 |
| Organism | Homo sapiens |
| Length | 425 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (55)
Diseases linked to this target (Open Targets).
- mean corpuscular volume · score 0.32
- mean corpuscular hemoglobin concentration · score 0.30
- hormone measurement · score 0.20
- dehydroepiandrosterone sulphate measurement · score 0.18
- sitting height measurement · score 0.13
- progesterone measurement · score 0.11
- body fat percentage · score 0.10
- reticulocyte count · score 0.10
- mean platelet volume · score 0.09
- age at first sexual intercourse measurement · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5FWF6-F1 | alphafold | PREDICTED | 68.26 | — |
Amino-acid sequence (425 residues)
MFPPARGKEL LSFEDVAMYF TREEWGHLNW GQKDLYRDVM LENYRNMVLL GFQFPKPEMI CQLENWDEQW ILDLPRTGNR KASGSACPGS EARHKMKKLT PKQKFSEDLE SYKISVVMQE SAEKLSEKLH KCKEFVDSCR LTFPTSGDEY SRGFLQNLNL IQDQNAQTRW KQGRYDEDGK PFNQRSLLLG HERILTRAKS YECSECGKVI RRKAWFDQHQ RIHFLENPFE CKVCGQAFRQ RSALTVHKQC HLQNKPYRCH DCGKCFRQLA YLVEHKRIHT KEKPYKCSKC EKTFSQNSTL IRHQVIHSGE KRHKCLECGK AFGRHSTLLC HQQIHSKPNT HKCSECGQSF GRNVDLIQHQ RIHTKEEFFQ CGECGKTFSF KRNLFRHQVI HTGSQPYQCV ICGKSFKWHT SFIKHQGTHK GQIST
Explore Zinc finger protein 789 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets